Novavax Stock Sees Big Gain After Positive FDA Update
Novavax’s stock price soared on May 19, 2025, after the FDA announced a promising development for the company’s COVID-19 vaccine. The stock surged over 15%, marking one of its largest gains in recent times. The FDA confirmed that a late-stage clinical trial had shown high efficacy and safety for Novavax’s COVID-19 vaccine candidate. This news … Read more